Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its ...

In the gap between rhetoric and action, plenty of space exists for others, including his own advisers, to impose their own ...

25."A man in his thirties was suddenly at the door. He was crunched over like he was having severe abdominal pain. He was ...

A study of efforts to limit or prevent COVID-19 in nursing homes shows that many steps were unproven and gave little or no conclusive help.

Here are more doctors and nurses who are willing to share their shocking experiences, sourced from the BuzzFeed Community, and questions like "What's the craziest thing you have seen at a hospital?" ...

The British charts began in 1952, initially populated by crooners and ... with The Who and The Kinks also adding a unique Englishness. In the mid-Sixties the drugs hit - LSD sent pop looking for ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Three teenagers are among 73 individuals who have died from the flu this season, according to San Diego County’s latest ...